알레르기비염 치료에 따른 호기산화질소와 비강 내 산화질소 수치 변화
Changes in levels of fractional exhaled and nasal nitric oxide after treatment in allergic rhinitis
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Recent studies have reported that nasal nitric oxide (NO) increases in patients with allergic rhinitis (AR) and bronchial asthma (BA), and can be used as a noninvasive test to determine treatment efficacy. We aimed to investigate the changes in fractional exhaled NO (FeNO) and nasal NO levels before and after treatment in patients with AR and asthma. Methods: Children aged 6–18 years who visited Dong-A University Hospital from August 2013 to July 2014 were treated for mild-persistent or severe-intermittent AR according to Allergic Rhinitis and its Impact on Asthma guidelines. FeNO and nasal NO were measured using NObreath. Among all patients, rhinitis was treated for 1 month, and the results were evaluated in patients with improved AR (n=31), improved AR+BA (n=23), and control (n=19) groups. Results: Sex, age, body mass index, allergy, serum total eosinophil count and immunoglobulin E, erythrocyte sedimentation rate, and C-reactive protein showed no intergroup differences before or after treatment. Nasal NO before treatment was higher in the BA+AR and AR groups than controls (P=0.005), but there was no difference between disease groups after treatment. Both groups showed a significant decrease in nasal NO after treatment compared with measurements before treatment (AR, P=0.044; AR+BA, P=0.004). Conclusion: Nasal NO can be effectively used as a noninvasive test for clinical efficacy because it was significantly reduced by improving symptoms in AR patients with and without asthma.
Abstract
Purpose: Recent studies have reported that nasal nitric oxide (NO) increases in patients with allergic rhinitis (AR) and bronchial asthma (BA), and can be used as a noninvasive test to determine treatment efficacy. We aimed to investigate the changes in fractional exhaled NO (FeNO) and nasal NO levels before and after treatment in patients with AR and asthma. Methods: Children aged 6–18 years who visited Dong-A University Hospital from August 2013 to July 2014 were treated for mild-persistent or severe-intermittent AR according to Allergic Rhinitis and its Impact on Asthma guidelines. FeNO and nasal NO were measured using NObreath. Among all patients, rhinitis was treated for 1 month, and the results were evaluated in patients with improved AR (n=31), improved AR+BA (n=23), and control (n=19) groups. Results: Sex, age, body mass index, allergy, serum total eosinophil count and immunoglobulin E, erythrocyte sedimentation rate, and C-reactive protein showed no intergroup differences before or after treatment. Nasal NO before treatment was higher in the BA+AR and AR groups than controls (P=0.005), but there was no difference between disease groups after treatment. Both groups showed a significant decrease in nasal NO after treatment compared with measurements before treatment (AR, P=0.044; AR+BA, P=0.004). Conclusion: Nasal NO can be effectively used as a noninvasive test for clinical efficacy because it was significantly reduced by improving symptoms in AR patients with and without asthma.
참고문헌 (32)
- 지혜미, "2006년 초등학생의 알레르기 질환 유병률의 전국적 역학조사", Allergy Asthma & Respiratory Disease, 19(2), pp.165~172 (2009), 대한 소아알레르기 호흡기학회
- Bousquet J, "World Health Organization; GA (2) LEN; AllerGen. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen)", Allergy, 63(Suppl 86), pp.8~160 (2008)
- Passalacqua G, "The nose-lung interaction in allergic rhinitis and asthma : united airways disease", Curr Opin Allergy Clin Immunol, 1, pp.7~13 (2001)
- Togias A, "Rhinitis and asthma : evidence for respiratory system integration", J Allergy Clin Immunol, 111, pp.1171~1183 (2003)
- Van Den Nieuwenhof L, "Is physician-diagnosed allergic rhinitis a risk factor for the development of asthma?", Allergy, 65, pp.1049~1055 (2010)
- 문승현, "우리나라 소아 알레르기비염 환자에서 호기산화질소의 측정", Allergy Asthma & Respiratory Disease, 3(6), pp.439~445 (2015), 대한 소아알레르기 호흡기학회[DOI]
- 안지영, "소아에서 알레르기 및 비알레르기비염의 임상 증상 비교", Allergy Asthma & Respiratory Disease, 3(5), pp.341~345 (2015), 대한 소아알레르기 호흡기학회[DOI]
- Arnal JF, "Nasal nitric oxide is increased in allergic rhinitis", Clin Exp Allergy, 27, pp.358~362 (1997)
- Stewart L, "Exhaled nitric oxide", Immunol Allergy Clin North Am, 32, pp.347~362 (2012)
- Martin U, "Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis", J Allergy Clin Immunol, 97, pp.768~772 (1996)
- Guida G, "Determinants of exhaled nitric oxide in chronic rhinosinusitis", Chest, 137, pp.658~664 (2010)
- Rolla G, "Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma : a clinical study of a consecutive series of patients", Chest, 131, pp.1345~1352 (2007)
- Takeno S, "Measurements of nasal fractional exhaled nitric oxide with a hand-held device in patients with allergic rhinitis : relation to cedar pollen dispersion and laser surgery", Allergol Int, 61, pp.93~100 (2012)
- Dweik RA, "An official ATS clinical practice guideline : interpretation of exhaled nitric oxide levels(FENO)for clinical applications", Am J Respir Crit Care Med, 184, pp.602~615 (2011)
- Hanson JR, "Office-based exhaled nitric oxide measurement in children 4 years of age and older", Ann Allergy Asthma Immunol, 111, pp.358~363 (2013)
- Linhares D, "Effects of atopy and rhinitis on exhaled nitric oxide values-a systematic review", Clin Transl Allergy, 1, pp.8~ (2011)
- Sonnappa S, "Ethnic differences in fraction of exhaled nitric oxide and lung function in healthy young children", Chest, 140, pp.1325~1331 (2011)
- van Weel C, "Asthma management pocket reference 2008", Allergy, 63, pp.997~1004 (2008)
- Chawes BLK, "Children with allergic and nonallergic rhinitis have a similar risk of asthma", J Allergy Clin Immunol, 126, pp.567~573 (2010)
- Johansson S, "In vitro assays for immunoglobulin E. Methodology, indications, and interpretation", Clin Rev Allergy, 6, pp.93~139 (1988)
- Dawson TM, "Gases as biological messengers : nitric oxide and carbon monoxide in the brain", J Neurosci, 14, pp.5147~5159 (1994)
- Kharitonov SA, "Increased nitric oxide in exhaled air of asthmatic patients", Lancet, 343, pp.133~135 (1994)
- Lundberg J, "Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa", Eur Respir J, 9, pp.1344~1347 (1996)
- Colantonio D, "Paradoxical low nasal nitric oxide in nasal polyposis", Clin Exp Allergy, 32, pp.698~701 (2002)
- Sato M, "Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa-indices for severe perennial nasal allergy", Clin Exp Allergy, 28, pp.597~605 (1998)
- Wang PP, "Nasal nitric oxide in allergic rhinitis in children and its relationship to severity and treatment", Allergy Asthma Clin Immunol, 13, pp.20~ (2017)
- Lei Ren, "Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms", Allergy, Asthma & Immunology Research, 11(3), pp.367~380 (2019), 대한천식알레르기학회
- Takeno S, "The role of nasal fractional exhaled nitric oxide as an objective parameter independent of nasal airflow resistance in the diagnosis of allergic rhinitis", Auris Nasus Larynx, 44, pp.435~441 (2017)
- Moncada S, "Nitric oxide : physiology, pathophysiology and pharmacology", Pharmacol Rev, 43, pp.109~142 (1991)
- Persson MG, "Single-breath nitric oxide measurements in asthmatic patients and smokers", Lancet, 343, pp.146~147 (1994)
- Vass G, "The effect of allergic rhinitis on adenosine concentration in exhaled breath condensate", Clin Exp Allergy, 36, pp.742~747 (2006)
- Antosova M, "Exhaled and nasal nitric oxide–impact for allergic rhinitis", Physiol Res, 69, pp.123~130 (2020)